Cancer and ageing: convergent and divergent mechanisms
The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Abstract
Cancer and ageing are both fuelled by the accumulation of cellular damage. Consequently, those mechanisms that protect cells from damage simultaneously provide protection against cancer and ageing. By contrast, cancer and longevity require a durable cell proliferation potential and, therefore, those mechanisms that limit indefinite proliferation provide cancer protection but favour ageing. The overall balance between these convergent and divergent mechanisms guarantees fitness and a cancer-free life until late adulthood for most individuals.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Overall, we recognise that these kinds of inflammatory, oxidative stress-related reactions are accumulative and somewhat irreversible [161], that they are consequently age-related, and (see [162-165] and later), and that most diseases and causes of mortality that are prevalent in the developed world are in this sense largely manifestations of this kind of aging.”
Citations
Cites
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Self-citationResveratrol improves health and survival of mice on a high-calorie diet
Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., et al. (2006) · Nature · doi:10.1038/nature05354 · Cited by 4,290
Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliott, P., et al. (2006) · Cell · doi:10.1016/j.cell.2006.11.013 · Cited by 4,057 · cited 1×
“, as well as that of mice that are fed on a high-fat hypercaloric die”
BackgroundTherapeutic potential of resveratrol: the in vivo evidence
Baur, J. A., & Sinclair, D. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2060 · Cited by 3,958
Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1
Rodgers, J. T., Lerin, C., Haas, W., Gygi, S. P., Spiegelman, B. M., & Puigserver, P. (2005) · Nature · doi:10.1038/nature03354 · Cited by 3,160 · cited 1×
“Upon nutrient scarcity, SIRT1 implements a metabolic programme that is, in part, mediated by the association of SIRT1 with the transcription factor PGC1α, the main result of which is an improved metabolic efficiency and, hence, reduced generation of RO”
BackgroundShelterin: the protein complex that shapes and safeguards human telomeres
de Lange, T. (2005) · Genes & Development · doi:10.1101/gad.1346005 · Cited by 3,056 · cited 1×
“Telomeres are nucleoprotein structures that protect the ends of chromosomes from unscheduled DNA repair and degradatio”
BackgroundSenescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473 · cited 1×
“Current data indicate that senescent cells can be efficiently cleared from the organis”
BackgroundVousden, K. H., & Lane, D. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2147 · Cited by 2,272
BRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
Chen, Z., Trotman, L. C., Shaffer, D., Lin, H.-K., Dotan, Z. A., Niki, M., Koutcher, J. A., Scher, H. I., Ludwig, T., Gerald, W., et al. (2005) · Nature · doi:10.1038/nature03918 · Cited by 1,993
Cited by
Linking functional decline of telomeres, mitochondria and stem cells during ageing
Sahin, E., & DePinho, R. A. (2010) · Nature · doi:10.1038/nature08982 · Cited by 759
“Finally, inactivation of p53 may not be sufficient to sustain viability in the setting of extremely severe telomere dysfunction and rampant chromosomal stabilit”
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
“age-related, and (see [162-165] and later), and that most”
BackgroundRedox regulation by NRF2 in aging and disease
Schmidlin, C. J., Dodson, M. B., Madhavan, L., & Zhang, D. D. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.01.016 · Cited by 434
Agger, K., Cloos, P. A. C., Rudkjær, L., Williams, K., Andersen, G., Christensen, J., & Helin, K. (2009) · Genes & Development · doi:10.1101/gad.510809 · Cited by 427
“Senescence induced by oncogenes and other stress signals has been identified as a fail-safe program that counters malignant transformation (Serrano and Blasco 2007; Prieur and Peeper 2008).”
BackgroundHair follicle aging is driven by transepidermal elimination of stem cells via COL17A1 proteolysis
Matsumura, H., Mohri, Y., Binh, N. T., Morinaga, H., Fukuda, M., Ito, M., Kurata, S., Hoeijmakers, J., & Nishimura, E. K. (2016) · Science · doi:10.1126/science.aad4395 · Cited by 416
The ageing immune system: is it ever too old to become young again?
Dorshkind, K., Montecino-Rodriguez, E., & Signer, R. A. J. (2009) · Nature Reviews Immunology · doi:10.1038/nri2471 · Cited by 412
Opposing roles for p16Ink4a and p19Arf in senescence and ageing caused by BubR1 insufficiency
Baker, D. J., Perez-Terzic, C., Jin, F., Pitel, K. S., Niederländer, N. J., Jeganathan, K., Yamada, S., Reyes, S., Rowe, L., Hiddinga, H. J., et al. (2008) · Nature Cell Biology · doi:10.1038/ncb1744 · Cited by 408
“It has been proposed that the p19 Arf –p53 pathway in response to low, chronic stress, may primarily induce genes that promote cell survival and repair, thereby extending lifespa”
Aging and disease as modifiers of efficacy of cell therapy
Dimmeler, S., & Leri, A. (2008) · Circulation Research · doi:10.1161/circresaha.108.175943 · Cited by 379
Pten positively regulates brown adipose function, energy expenditure, and longevity
Ortega-Molina, A., Efeyan, A., Lopez-Guadamillas, E., Muñoz-Martin, M., Gómez-López, G., Cañamero, M., Mulero, F., Pastor, J., Martinez, S., Romanos, E., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.02.001 · Cited by 356
Self-citationCentrosome misorientation reduces stem cell division during ageing
Cheng, J., Türkel, N., Hemati, N., Fuller, M. T., Hunt, A. J., & Yamashita, Y. M. (2008) · Nature · doi:10.1038/nature07386 · Cited by 355
“Tissue ageing has been proposed to have arisen as a tumour suppressor mechanism 6,7 , in which tumour suppressor activity reduces stem cell function in later stages of life, preventing tumorigenesis but reducing tissue regenerative capacity 8 .”
Cao, L., Xu, X., Bunting, S. F., Liu, J., Wang, R.-H., Cao, L. L., Wu, J. J., Peng, T.-N., Chen, J., Nussenzweig, A., et al. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.06.037 · Cited by 309
“…a number of mammalian models of chronic DNA damage and genomic instability are characterized by exhibiting both 534 Molecular Cell 35, 534–541, August 28, 2009 ª2009 Elsevier Inc a tumor-prone and accelerated aging phenotype (Chen et al., 2007; Lombard et al., 2005; Serrano and Blasco, 2007).”
BackgroundGene expression changes with age in skin, adipose tissue, blood and brain
Glass, D., Viñuela, A., Davies, M. N., Ramasamy, A., Parts, L., Knowles, D., Brown, A. A., Hedman, Å. K., Small, K. S., Buil, A., et al. (2013) · Genome Biology · doi:10.1186/gb-2013-14-7-r75 · Cited by 285
“Regarding cancer and aging, Serrano and Blasco (2007) suggested that an equilibrium between mechanisms diminishing cellular damage and mechanisms preventing excessive cellular proliferation is required between both processes [43].”
Senescent Cells: A Novel Therapeutic Target for Aging and Age-Related Diseases
Naylor, R. M., Baker, D. J., & van Deursen, J. M. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.193 · Cited by 280
Self-renewal and differentiation capacity of young and aged stem cells
Roobrouck, V. D., Ulloa-Montoya, F., & Verfaillie, C. M. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.03.006 · Cited by 268
“response mechanisms to DNA damage and telomere shortening, suggesting that some of the same mechanisms that prevent the accumulation of damaged stem cells (anti-cancer mechanisms) might be involved in their decreased functionality or exhaustion with aging [37].”
The Genetics of Aging: A Vertebrate Perspective
Singh, P. P., Demmitt, B. A., Nath, R. D., & Brunet, A. (2019) · Cell · doi:10.1016/j.cell.2019.02.038 · Cited by 259
Telomerase at the intersection of cancer and aging
Bernardes de Jesus, B., & Blasco, M. A. (2013) · Trends in Genetics · doi:10.1016/j.tig.2013.06.007 · Cited by 227
Self-citationImpact of aging on the biology of breast cancer
Benz, C. C. (2008) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2007.09.001 · Cited by 245
“The tumor suppressing proteins p53 and p16INK4a (product of the INK4a/ARF locus) have been linked to both aging and tumorigenesis in animal models [17,18]; and it has recently been argued that these two key regulators direct convergent and divergent cellular mechanisms, respectively, that evolved to protect against ca…”
BackgroundOn the Programmed/Non-Programmed Nature of Ageing within the Life History
Kirkwood, T. B. L., & Melov, S. (2011) · Current Biology · doi:10.1016/j.cub.2011.07.020 · Cited by 246
Age-induced accumulation of methylmalonic acid promotes tumour progression
Gomes, A. P., Ilter, D., Low, V., Endress, J. E., Fernández-García, J., Rosenzweig, A., Schild, T., Broekaert, D., Ahmed, A., Planque, M., et al. (2020) · Nature · doi:10.1038/s41586-020-2630-0 · Cited by 244
A review of the pathophysiological mechanisms of doxorubicin-induced cardiotoxicity and aging
Linders, A. N., Dias, I. B., López Fernández, T., Tocchetti, C. G., Bomer, N., & Van der Meer, P. (2024) · npj Aging · doi:10.1038/s41514-024-00135-7 · Cited by 231
A GLI1-p53 inhibitory loop controls neural stem cell and tumour cell numbers
Stecca, B., & Ruiz i Altaba, A. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.16 · Cited by 233
“Whereas its imbalance in favour of p53 could affect stem cell lineages and aging (Serrano and Blasco, 2007), imbalance in favour of GLI1 appears to be predominant in cancer and cancer stem cells.”
BackgroundSenescence: a new weapon for cancer therapy
Acosta, J. C., & Gil, J. (2012) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.11.006 · Cited by 223
Cell cycle arrest is not senescence
Blagosklonny, M. V. (2011) · Aging · doi:10.18632/aging.100281 · Cited by 217
“This extends the notion that the secretory phenotype contributes to cancer and that cancer and aging have a lot in common [22,66-68].”
BackgroundRelevance of the p53–MDM2 axis to aging
Wu, D., & Prives, C. (2018) · Cell Death & Differentiation · doi:10.1038/cdd.2017.187 · Cited by 215
Loss of Heterozygosity (LOH) Profiles—Validated Risk Predictors for Progression to Oral Cancer
Zhang, L., Poh, C. F., Williams, M., Laronde, D. M., Berean, K., Gardner, P. J., Jiang, H., Wu, L., Lee, J. J., & Rosin, M. P. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-12-0173 · Cited by 212
“org Cancer Prev Res; 5(9) September 2012 1085”
BackgroundInfluentialEpigenetic regulation of the INK4b-ARF-INK4a locus: In sickness and in health
Popov, N., & Gil, J. (2010) · Epigenetics · doi:10.4161/epi.5.8.12996 · Cited by 202
20 years studying p53 functions in genetically engineered mice
Donehower, L. A., & Lozano, G. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2731 · Cited by 168
Astaxanthin protects mitochondrial redox state and functional integrity against oxidative stress
Wolf, A. M., Asoh, S., Hiranuma, H., Ohsawa, I., Iio, K., Satou, A., Ishikura, M., & Ohta, S. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.01.011 · Cited by 191
“Oxidative stress is involved in the pathogenesis of atherosclerosis [1,2], cancer [3], diabetes [4,5], neurodegenerative [6–8] and other diseases, as well as in the aging process itself.”
BackgroundTelomeres in cancer and ageing
Donate, L. E., & Blasco, M. A. (2011) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2010.0291 · Cited by 190
Self-citationAging-Induced Stem Cell Mutations as Drivers for Disease and Cancer
Adams, P. D., Jasper, H., & Rudolph, K. L. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.05.002 · Cited by 180
“Importantly, metabolic interventions that increase longevity in mice tend to reduce the incidence of cancer (Serrano and Blasco, 2007).”
BackgroundTelomere Shortening in Neural Stem Cells Disrupts Neuronal Differentiation and Neuritogenesis
Ferrón, S. R., Marqués-Torrejón, M. Á., Mira, H., Flores, I., Taylor, K., Blasco, M. A., & Fariñas, I. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3836-09.2009 · Cited by 179
“…displayed by p53-deficient cells (Gil-Perotin et al., 2006; Meletis et al., 2006; our present data) can be counteracted by telomere shortening supports the notion that absence of telomere maintenance in postnatal individuals may act as a tumor-suppressive mechanism (Serrano and Blasco, 2007).”
BackgroundSelf-citationIL-6-STAT3 signaling and premature senescence
Kojima, H., Inoue, T., Kunimoto, H., & Nakajima, K. (2013) · JAK-STAT · doi:10.4161/jkst.25763 · Cited by 170
“A number of actively mutated oncogenes, including Ras, Raf, MEK, and c-Myc, or inactivated tumor suppressor genes, including PTEN, have been shown to induce premature senescence.(15,16) This type of senescence is called oncogene-induced senescence (OIS).”
BackgroundDerhovanessian, E., Solana, R., Larbi, A., & Pawelec, G. (2008) · Immunity & Ageing · doi:10.1186/1742-4933-5-11 · Cited by 169
“This can be due to different reasons, such as increased duration of carcinogenesis or the susceptibility of aging cells to environmental carcinogens [2,3].”
BackgroundmTOR's role in ageing: protein synthesis or autophagy?
Hands, S. L., Proud, C. G., & Wyttenbach, A. (2009) · Aging · doi:10.18632/aging.100070 · Cited by 159
“ageing [97, 98].”
Telomerase, senescence and ageing
Shawi, M., & Autexier, C. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2007.11.007 · Cited by 170
“Thus, telomeres have increasingly gained attention due to their role in cancer and ageing (Blasco, 2005; Collado et al., 2007; Moon and Jarstfer, 2007; Serrano, 2007; Serrano and Blasco, 2007).”
Aging by epigenetics—A consequence of chromatin damage?
Sedivy, J. M., Gowrishankar, B., & Adams, P. D. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.02.023 · Cited by 170
“renewal of tissues [61–63].”
Oxidative stress-related aging: A role for prostate cancer?
Minelli, A., Bellezza, I., Conte, C., & Čulig, Z. (2008) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2008.11.001 · Cited by 159
Inflammation, ageing and cancer
Vasto, S., Carruba, G., Lio, D., Colonna‐Romano, G., Bona, D. D., Candore, G., & Caruso, C. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2008.06.003 · Cited by 154
S6K1 is a multifaceted regulator of Mdm2 that connects nutrient status and DNA damage response
Lai, K. P., Leong, W. F., Chau, J. F. L., Jia, D., Zeng, L., Liu, H., He, L., Hao, A., Zhang, H., Meek, D. W., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.166 · Cited by 136
“(Serrano and Blasco, 2007).”
BackgroundLanni, C., Masi, M., Racchi, M., & Govoni, S. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-0760-2 · Cited by 130
Lithocholic bile acid selectively kills neuroblastoma cells, while sparing normal neuronal cells
Goldberg, A. A., Beach, A., Davies, G. F., Harkness, T. A. A., LeBlanc, A. C., & Titorenko, V. I. (2011) · Oncotarget · doi:10.18632/oncotarget.338 · Cited by 119
“, manuscript in preparation), a cytoprotective anti-aging process that in different situations can play either an anti-cancer or a pro-cancer role [8,9,15-23,80-85].”
InfluentialInduced pluripotent stem cells and senescence: learning the biology to improve the technology
Banito, A., & Gil, J. (2010) · EMBO reports · doi:10.1038/embor.2010.47 · Cited by 107
“Complex mouse models have suggested that we could theoretically exploit the positive effects of senescence in tumour suppression while avoiding unwanted side effects such as premature ageing (Serrano & Blasco, 2007).”
BackgroundAntiaging agents: safe interventions to slow aging and healthy life span extension
Liu, J.-K. (2022) · Natural Products and Bioprospecting · doi:10.1007/s13659-022-00339-y · Cited by 105
“Furthermore, the delicate balance between maintaining the stem cell pool and suppressing tumors should be carefully considered [293].”
BackgroundRuzankina, Y., Schoppy, D. W., Asare, A., Clark, C. E., Vonderheide, R. H., & Brown, E. J. (2009) · Nature Genetics · doi:10.1038/ng.441 · Cited by 97
“and by limiting the accumulation of damaged cells that impede repopulation from competent progenitor”
Song, X., Narzt, M. S., Nagelreiter, I. M., Hohensinner, P., Terlecki-Zaniewicz, L., Tschachler, E., Grillari, J., & Gruber, F. (2017) · Redox Biology · doi:10.1016/j.redox.2016.12.015 · Cited by 101
Qin, X., Fukuda, T., Yang, L., Zaha, H., Akanuma, H., Zeng, Q., Yoshinaga, J., & Sone, H. (2012) · Cancer Biology & Therapy · doi:10.4161/cbt.18942 · Cited by 112
“Indeed, there has been increased attention on the balance between convergent and divergent mechanisms of cancer and aging.(14,15) Both cancer and aging are fuelled by the accumulation of cellular damage.”
BackgroundInfluentialPiskunova, T. S., Yurova, M. N., Ovsyannikov, A. I., Semenchenko, A. V., Zabezhinski, M. A., Popovich, I. G., Wang, Z.-Q., & Anisimov, V. N. (2008) · Current Gerontology and Geriatrics Research · doi:10.1155/2008/754190 · Cited by 101
“Previous studies have demonstrated that deficiency or inactivation of PARP-1 cause a high degree of genomic stability, characterized by aneuploidy, increased sister chromatid exchange, chromosome gain or loss, and telomere shortening [2, 11].”
BackgroundSpontaneous Calcium Oscillations Regulate Human Cardiac Progenitor Cell Growth
Ferreira‐Martins, J., Rondon-Clavo, C., Tugal, D., Korn, J. A., Rizzi, R., Padín-Iruegas, E., Ottolenghi, S., Angelis, A. D., Urbanek, K., Ide-Iwata, N., et al. (2009) · Circulation Research · doi:10.1161/circresaha.109.206698 · Cited by 91
Aging-Associated Changes in Hematopoiesis and Leukemogenesis: What's the Connection?
Henry, C. J., Marusyk, A., & DeGregori, J. (2011) · Aging · doi:10.18632/aging.100351 · Cited by 85
Salminen, A., Kaarniranta, K., & Kauppinen, A. (2016) · Biogerontology · doi:10.1007/s10522-016-9655-7 · Cited by 94
“Aging and cancers display totally different changes at the level of histology although there seems to be both divergent and convergent molecular mechanisms driving the aging process and carcinogenesis (Serrano and Blasco 2007; de Magalhaes 2013).”
Li, T., Liu, X., Jiang, L., Manfredi, J., Zha, S., & Gu, W. (2016) · Oncotarget · doi:10.18632/oncotarget.7864 · Cited by 85
“Normal proliferating cells constantly cope with a variety of stress signals from both outside and inside such as replication stress, telomere shortening and ROS damage, and their genome integrity are inevitably damaged during proliferation, which can induce a p53mediated temporary arrest at cell cycle checkpoints to a…”
BackgroundDeGregori, J. (2013) · Oncogene · doi:10.1038/onc.2012.281 · Cited by 84
Aging and cardiovascular diseases: the role of gene-diet interactions
Corella, D., & Ordovás, J. M. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.08.002 · Cited by 83
Bladder cancer in the elderly: clinical outcomes, basic mechanisms, and future research direction
Taylor, J. A., & Kuchel, G. A. (2009) · Nature Reviews Urology · doi:10.1038/ncpuro1315 · Cited by 88
“antioxidant defenses), while the pathways regulating cellular proliferation typically exert divergent or opposing effects; specifically, protecting from cancer but promoting aging”
Galderisi, U., Helmbold, H., Squillaro, T., Alessio, N., Komm, N., Khadang, B., Cipollaro, M., Bohn, W., & Giordano, A. (2009) · Stem Cells and Development · doi:10.1089/scd.2008.0324 · Cited by 76
“Senescence signals that engage the p16 INK4A –RB pathway generally do so by inducing the expression of p16 INK4A , another CKI that prevents RB1 phosphorylation and inactivation [1,2,38].”
InfluentialBioactive Nutrients and Nutrigenomics in Age-Related Diseases
Rescigno, T., Micolucci, L., Tecce, M., & Capasso, A. (2017) · Molecules · doi:10.3390/molecules22010105 · Cited by 74
“This may be due to various reasons such as increased duration of exposure to carcinogenic factors, stronger cell susceptibility to environmental carcinogens [88, 89] or to the immunosenescence in elderly [90].”
BackgroundMitochondria as sources and targets of damage in cellular aging
Gomez-Cabrera, M. C., Sanchis-Gomar, F., Garcia-Valles, R., Pareja-Galeano, H., Gambini, J., Borras, C., & Viña, J. (2012) · Clinical Chemistry and Laboratory Medicine · doi:10.1515/cclm-2011-0795 · Cited by 72
“In addition, increased lifespan is observed in mouse models that overexpress telomerase, although the probabilities of initiating a tumour are higher (82, 83) .”
BackgroundGolomb, L., Sagiv, A., Pateras, I. S., Maly, A., Krizhanovsky, V, Gorgoulis, V. G., Oren, M., & Ben-Yehuda, A. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2015.21 · Cited by 71
“Yet, aging remains the strongest single risk factor for cancer development.(1,2) One example of an age-related cancer is cutaneous squamous cell carcinoma (SCC).”
BackgroundS-adenosylhomocysteine hydrolase downregulation contributes to tumorigenesis
Martínez-Leal, J. F., Ferrer, I., Blanco‐Aparicio, C., Hernández‐Losa, J., y Cajal, S. R., Carnero, A., & LLeonart, M. E. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn198 · Cited by 75
Model of human aging: Recent findings on Werner’s and Hutchinson-Gilford progeria syndromes
Ding, S.-L., & Shen, C.-Y. (2008) · Clinical Interventions in Aging · doi:10.2147/cia.s1957 · Cited by 69
“Importantly, the rate of DNA damage production increases with ageing (Hasty and Vijg 2004; Serrano and Blasco 2007).”
Hatse, S., Brouwers, B., Dalmasso, B., Laenen, A., Kenis, C., Schöffski, P., & Wildiers, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110644 · Cited by 67
“While being a potent anti-tumor mechanism early in life, cellular senescence is at the same time responsible for tissue aging at older age, through accumulation of non-proliferative cells [13], finally resulting in tissue dysfunction and age-related diseases.”
BackgroundMarusyk, A., & DeGregori, J. V. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2007.09.001 · Cited by 80
“Therefore, the prevailing logic linking aging and cancer rates is straightforward: increasing age leads to the accumulation of genomic changes, and since some of these mutations and epigenetic events are expected to be oncogenic, the chance of developing a malignancy should increase with age dependent on the buildup o…”
BackgroundSantacatterina, F., Sánchez-Cenizo, L., Formentini, L., Mobasher, M. A., Casas, E., Rueda, C. B., Martínez‐Reyes, I., de Arenas, C. N., García‐Bermúdez, J., Zapata, J. M., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6357 · Cited by 69
“Recent findings in in vivo mouse models indicate that the activation of mitochondrial OXPHOS provides a tumor-suppressive metabolic state [5, 40].”
BackgroundCarcinogenesis and aging 20 years after: Escaping horizon
Anisimov, V. N. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2008.02.004 · Cited by 78
“Both carcinogenesis and aging are associated with genomic alterations, which may act synergistically in causing cancer (Hanahan and Weinberg, 2000; Finkel et al., 2007; Serrano and Blasco, 2007).”
BackgroundChen, L., Yang, R., Qiao, W., Yuan, X., Wang, S., Goltzman, D., & Miao, D. (2018) · International Journal of Cancer · doi:10.1002/ijc.31317 · Cited by 67
“Age is the strongest demographic risk factor for most human malignancies(31) and aging is involved in a number of events responsible for carcinogenesis and cancer development at the molecular, cellular and tissue levels.(10,32) Thus, accumulating evidence shows that aging-induced senescent cells secrete molecules that…”
BackgroundLiu, Y., Liu, F., Yu, H., Zhao, X., Sashida, G., DeBlasio, A., Harr, M. W., She, Q., Chen, Z., Lin, H., et al. (2012) · Science Signaling · doi:10.1126/scisignal.2003199 · Cited by 73
“Oncogene-induced senescence is an important barrier to tumorigenesis (57, 58), and Bmi suppresses the expression of Ink4a-Arf locus, which encodes two tumor suppressors that are key regulators of senescence (p16 and p19 ) (17).”
Sánchez‐Aragó, M., Formentini, L., & Cuezva, J. M. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4883 · Cited by 69
“Tumor suppressors such as Pten, p53, Ink4a, and Arf are known to exert a beneficial pleiotropic effect in cell physiology against aging and metabolic disease, in addition to provide protection against cancer (82).”
Gupta, S., De, S., Srivastava, V., Hussain, M., Kumari, J., Muniyappa, K., & Sengupta, S. (2014) · Carcinogenesis · doi:10.1093/carcin/bgt315 · Cited by 62
Ethnicity and survival in bladder cancer: a population-based study based on the SEER database
Fang, W., Yang, Z.-Y., Chen, T., Shen, X., & Zhang, C. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02308-w · Cited by 62
The dual role of p53: DNA protection and antioxidant
Borrás, C., Gómez-Cabrera, M. C., & Viña, J. (2011) · Free Radical Research · doi:10.3109/10715762.2011.571685 · Cited by 59
Death and dessert: nutrient signalling pathways and ageing
Alic, N., & Partridge, L. (2011) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2011.07.006 · Cited by 59
“The functioning of the IIS and TOR pathways appears mostly to support the agonistic relationship between cancer and ageing, while the functioning of other pathways may not [60].”
BackgroundInfluentialUsing Mice to Examine p53 Functions in Cancer, Aging, and Longevity
Donehower, L. A. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001081 · Cited by 55
Rozhok, A. I., Salstrom, J. L., & DeGregori, J. (2014) · Aging · doi:10.18632/aging.100707 · Cited by 55
“The Somatic Mutation Theory of Aging postulates that the accumulation of somatic DNA alterations with age largely accounts for aging phenotypes [1-4].”
BackgroundVogt, G. (2008) · International Journal of Cancer · doi:10.1002/ijc.23947 · Cited by 62
Real-Time Monitoring of Oxidative Stress in Live Mouse Skin
Wolf, A. M., Nishimaki, K., Kamimura, N., & Ohta, S. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.428 · Cited by 55
“…in the production of reactive oxygen species (ROS) over their elimination by endogenous antioxidants, is involved in the pathogenesis of cancer (Serrano and Blasco, 2007), inflammation and atherosclerosis (Lusis, 2000; Rocha and Libby, 2009), diabetes (Brownlee, 2001; Houstis et al., 2006),…”
Aging dependent effect of nuclear tau
Gil, L., Federico, C., Pinedo, F., Bruno, F., Poves, A. B. R., Montoya, J. J., Olazabal, I. M., Ferrer, I., & Saccone, S. (2017) · Brain Research · doi:10.1016/j.brainres.2017.09.030 · Cited by 55
“In epithelial cells the chromatin dynamics during aging are manifested differently, but it is widely accepted that aging stress can lead to tumoral development (Serrano and Blasco, 2007).”
Wu, D., Xu, H. Y., Chen, J., & Zhang, L. (2019) · International Journal for Vitamin and Nutrition Research · doi:10.1024/0300-9831/a000497 · Cited by 55
“Thesehumandisordersinclude atherosclerosis [ 4 ], cardiovascular diseases [ 5 ], cancer [ 6 ], diabetes [ 7 ], and neurodegenerative diseases [ 8 ].”
Rotblat, B., Grünewald, T. G. P., Leprivier, G., Melino, G., & Knight, R. A. (2013) · Oncotarget · doi:10.18632/oncotarget.1658 · Cited by 49
“It is interesting to note that the expression of AOS genes that are linked to aging is a feature of normal tissue in light of the discussion on the similarities and differences between expression of stress genes in cancer and aging [10, 17].”
BackgroundEffect of Ionizing Radiation Induced Damage of Endothelial Progenitor Cells in Vascular Regeneration
Lee, M.-O., Song, S., Jung, S.-Y., Hur, S., Asahara, T., Kim, S., Kwon, S., & Cha, H. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.237651 · Cited by 52
Reconvene and Reconnect the Antioxidant Hypothesis in Human Health and Disease
Singh, P. P., Chandra, A., Mahdi, F., Roy, A., & Sharma, P. (2010) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-010-0078-y · Cited by 57
Epperly, M. W., Dixon, T. M., Wang, H., Schlesselman, J. J., Franicola, D., & Greenberger, J. S. (2008) · Radiation Research · doi:10.1667/rr1286.1 · Cited by 46
Altered senescence, apoptosis, and DNA damage response in a mutant p53 model of accelerated aging
Hinkal, G. W., Gatza, C. E., Parikh, N., & Donehower, L. A. (2009) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2009.01.001 · Cited by 45
“The ability of tumor suppressors to induce apoptosis and senescence in response to cellular stress may play a role in the development of aging pathologies, as alterations in apoptosis and senescence have been associated with aging (Campisi, 2003; Serrano and Blasco, 2007).”
BackgroundThe molecular biology and therapeutic potential of Nrf2 in leukemia
Khodakarami, A., Adibfar, S., Karpisheh, V., Abolhasani, S., Jalali, P., Mohammadi, H., Navashenaq, J. G., Hojjat‐Farsangi, M., & Jadidi‐Niaragh, F. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02660-5 · Cited by 47
“Increased expression of Nrf2’s negative regulators and a general decrease in Nrf2 protein expression and pathway responsiveness have been attributed to Nrf2’s steady decline with age [156, 157].”
BackgroundPotential of telomerase activation in extending health span and longevity
de Jesus, B. B., & Blasco, M. A. (2012) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2012.09.004 · Cited by 44
“In this regard, increased gene dose of tumor suppressor genes that eliminate damage cells from the organism through apoptosis and senescence such as p53 and p16 are known to increase life span [14,15] furthermore, clearance of senescent cells from already-adult organisms also delays aging, thus confirming the involvem…”
BackgroundSelf-citationPolymorphisms of pro-inflammatory genes and prostate cancer risk: a pharmacogenomic approach
Caruso, C., Balistreri, C. R., Candore, G., Carruba, G., Colonna‐Romano, G., Bona, D. D., Forte, G. I., Lio, D., Listì, F., Scola, L., et al. (2009) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-009-0658-y · Cited by 46
“This may be due to diVerent reasons, such as an increased duration of carcinogenesis or the susceptibility of aging cells to environmental carcinogens [2, 3].”
Production of antimicrobial peptides is preserved in aging
Castañeda‐Delgado, J. E., Miranda-Castro, N. Y., González‐Amaro, R., Gonzalez-Curiel, I. E., Montoya-Rosales, A., Rivas-Calderon, B., & Rivas-Santiago, B. T. (2013) · Clinical Immunology · doi:10.1016/j.clim.2013.05.015 · Cited by 46
Telomeres And Telomerase in Adult Stem Cells and Pluripotent Embryonic Stem Cells
Marión, R. M., & Blasco, M. A. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-7037-4_9 · Cited by 52
Self-citationRegulation of fatty acid synthesis and Δ9-desaturation in senescence of human fibroblasts
Maeda, M., Scaglia, N., & Igal, R. A. (2009) · Life Sciences · doi:10.1016/j.lfs.2008.11.009 · Cited by 40
“Several studies have demonstrated the biological andmedical relevance of the senescence process in both ageing and cancer (reviewed by Serrano and Blasco, 2007).”
BackgroundMechanisms Underlying the Anti-Aging and Anti-Tumor Effects of Lithocholic Bile Acid
Arlia‐Ciommo, A., Piano, A., Svistkova, V., Mohtashami, S., & Titorenko, V. I. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150916522 · Cited by 40
“Significant progress has been made in our understanding of the intricate relationship that exists between the convergent and divergent mechanisms underlying aging and cancer [5,167–179].”
BackgroundGenetics and Pharmacology of Longevity
Castillo-Quan, J. I., Kinghorn, K. J., & Bjedov, I. (2015) · Advances in genetics · doi:10.1016/bs.adgen.2015.06.002 · Cited by 38
How does suppression of IGF-1 signaling by DNA damage affect aging and longevity?
Hinkal, G. W., & Donehower, L. A. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2008.02.005 · Cited by 40
“…to underlie central aspects of aging, so, unsurprisingly, increased attention has been paid to the role of p53 in regulating aging and longevity (Serrano and Blasco, 2007; Sharpless and DePinho, 2007) (Bauer and Helfand, 2006; Donehower and Levine, 2008; Gatza et al., 2005; Papazoglu and Mills,…”
Unraveling the links between cancer and aging
Serrano, M. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv100 · Cited by 33
“In fact, there are numerous manipulations that simultaneously increase longevity and cancer protection (1).”
BackgroundSelf-citationMarongiu, F., & DeGregori, J. V. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13275 · Cited by 43
Removing all obstacles: A critical role for p53 in promoting tissue renewal
Schoppy, D. W., Ruzankina, Y., & Brown, E. J. (2010) · Cell Cycle · doi:10.4161/cc.9.7.11194 · Cited by 32
Chatterjee, D., Kudlinzki, D., Linhard, V. L., Saxena, K., Schieborr, U., Gande, S. L., Wurm, J. P., Wöhnert, J., Abele, R., Rogov, V. V., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.660829 · Cited by 34
“Aging and several age-related diseases, including cancer, are fuelled by damage to the macromolecules in cells and tissues (60, 61).”
Backgroundde Lima, G. G., de Souza, G. B., Lepienski, C. M., & Kuromoto, N. K. (2016) · Journal of the mechanical behavior of biomedical materials/Journal of mechanical behavior of biomedical materials · doi:10.1016/j.jmbbm.2016.07.019 · Cited by 31
Tumor suppressor mechanisms in immune aging
Liu, Y., & Sharpless, N. E. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.05.011 · Cited by 30
Protein phosphatase 5 is necessary for ATR-mediated DNA repair
Kang, Y., Cheong, H.-M., Lee, J.-H., Song, P. I., Lee, K., Kim, S.-Y., Jun, J. Y., & You, H. J. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.12.005 · Cited by 31
Insights into Wild-Type and Mutant p53 Functions Provided by Genetically Engineered Mice
Donehower, L. A. (2014) · Human Mutation · doi:10.1002/humu.22507 · Cited by 29
The Intricate Interplay between Mechanisms Underlying Aging and Cancer
Piano, A., & Titorenko, V. I. (2014) · Aging and Disease · doi:10.14336/ad.2014.0209 · Cited by 30
“First, all cellular processes that in young and adult organisms affect the common to aging and cancer aetiologies are orchestrated by an intricate signaling network; the network integrates several signaling pathways and is centered at the mammalian (or mechanistic) target of rapamycin complex 1 (mTORC1) [1, 2, 13, 44,…”
BackgroundInfluential
Metadata
- Authors
- Serrano, M., & Blasco, M. A.
- Affiliations
- Spanish National Cancer Research Centre (ES)
- Corresponding author
- Serrano, Manuel
- ORCID
- Serrano, Manuel
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2007-09
- Volume
- 8
- Issue
- 9
- Pages
- 715-722
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W2087286926
- Cited by
- 182
- References
- 88
- Citations by year
- 2026: 5 · 2025: 2 · 2024: 3 · 2023: 3 · 2022: 3 · 2021: 3 · 2020: 6 · 2019: 7 · 2018: 5 · 2017: 8 · 2016: 12 · 2015: 11 · 2014: 12 · 2013: 12 · 2012: 17
- FWCI
- 1.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- cancer, aging, cellular senescence, cell proliferation, lifespan, cancer protection, longevity
- MeSH terms
- Aging, Animals, Humans, Neoplasms, Tumor Suppressor Protein p53, Cell Proliferation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.